SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines
Isidora Petrovic, Milena Milivojevic, Jelena Popovic, Marija Schwirtlich, Branislava Rankovic, Milena Stevanovic, Isidora Petrovic, Milena Milivojevic, Jelena Popovic, Marija Schwirtlich, Branislava Rankovic, Milena Stevanovic
Abstract
Although there is much evidence showing functional relationship between Hedgehog pathway, in particular Sonic hedgehog, and SOX transcription factors during embryonic development, scarce data are available regarding their crosstalk in cancer cells. SOX18 protein plays an important role in promoting tumor angiogenesis and therefore emerged as a promising potential target in antiangiogenic tumor therapy. Recently it became evident that expression of SOX18 gene in tumors is not restricted to endothelium of accompanying blood and lymphatic vessels, but in tumor cells as well.In this paper we have identified human SOX18 gene as a novel target gene of Hedgehog signaling in cervical carcinoma cell lines. We have presented data showing that expression of SOX18 gene is regulated by GLI1 and GLI2 transcription factors, final effectors of Hedgehog signaling, and that modulation of Hedgehog signaling activity in considerably influence SOX18 expression. We consider important that Hedgehog pathway inhibitors reduced SOX18 expression, thus showing, for the first time, possibility for manipulationwith SOX18 gene expression. In addition, we analyzed the role of SOX18 in malignant potential of cervical carcinoma cell line, and showed that its overexpression has no influence on cells proliferation and viability, but substantially promotes migration and invasion of cells in vitro. Pro-migratory effect of SOX18 suggests its role in promoting malignant spreading, possibly in response to Hedgehog activation.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15: 3059–87.
- Stone DM, Hynes M, Armanini M, Swanson TA, Gu Q, Johnson RL, et al. (1996) The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature. 384: 129–34.
- Villavicencio EH, Walterhouse DO, Iannaccone PM (2000) The sonic hedgehog-patched-gli pathway in human development and disease. Am J Hum Genet. 67: 1047–54.
- Hooper JE, Scott MP (2005) Communicating with Hedgehogs. Nat Rev Mol Cell Biol. 6: 306–17.
- Jiang J, Hui CC (2008) Hedgehog signaling in development and cancer. Dev Cell. 15: 801–12.
- Mullor JL, Sanchez P, Ruiz i Altaba A (2002) Pathways and consequences: Hedgehog signaling in human disease. Trends Cell Biol. 12: 562–9.
- Pasca di Magliano M, Hebrok M (2003) Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer. 3: 903–11.
- Lauth M, Toftgard R (2007) Non-canonical activation of GLI transcription factors: implications for targeted anti-cancer therapy. Cell Cycle. 6: 2458–63.
- Scales SJ, de Sauvage FJ (2009) Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci. 30: 303–12.
- Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, et al. (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells. Cancer Cell. 22: 373–88.
- Gu D, Liu H, Su GH, Zhang X, Chin-Sinex H, Hanenberg H, et al. (2013) Combining hedgehog signaling inhibition with focal irradiation on reduction of pancreatic cancer metastasis. Mol Cancer Ther. 12: 1038–48.
- Lin SH, George TJ, Ben-Josef E, Bradley J, Choe KS, Edelman MJ, et al. (2013) Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. J Natl Cancer Inst. 105: 686–93.
- Ramaswamy B, Lu Y, Teng KY, Nuovo G, Li X, Shapiro CL, et al. (2012) Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway. Cancer Res. 72: 5048–59.
- Pevny LH, Lovell-Badge R (1997) Sox genes find their feet. Curr Opin Genet Dev. 7: 338–44.
- Wegner M (1999) From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 27: 1409–20.
- Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, Amodeo R, et al. (2008) Sox18 and Sox7 play redundant roles in vascular development. Blood. 111: 2657–66.
- Matsui T, Kanai-Azuma M, Hara K, Matoba S, Hiramatsu R, Kawakami H, et al. (2006) Redundant roles of Sox17 and Sox18 in postnatal angiogenesis in mice. J Cell Sci. 119: 3513–26.
- Darby IA, Bisucci T, Raghoenath S, Olsson J, Muscat GE, Koopman P (2001) Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest. 81: 937–43.
- Young N, Hahn CN, Poh A, Dong C, Wilhelm D, Olsson J, et al. (2006) Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. J Natl Cancer Inst. 98: 1060–7.
- Pula B, Olbromski M, Wojnar A, Gomulkiewicz A, Witkiewicz W, Ugorski M, et al. (2013) Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma. Cell Oncol (Dordr). 36: 469–83.
- Hargrave M, Karunaratne A, Cox L, Wood S, Koopman P, Yamada T (2000) The HMG box transcription factor gene Sox14 marks a novel subset of ventral interneurons and is regulated by sonic hedgehog. Dev Biol. 219: 142–53.
- Scotting PJ, Rex M (1996) Transcription factors in early development of the central nervous system. Neuropathol Appl Neurobiol. 22: 469–81.
- Milivojevic M, Petrovic I, Kovacevic-Grujicic N, Popovic J, Mojsin M, Stevanovic M (2013) Construction and functional analysis of novel dominant-negative mutant of human SOX18 protein. Biochemistry (Mosc). 78: 1287–92.
- Petrovic I, Kovacevic-Grujicic N, Stevanovic M (2010) Early growth response protein 1 acts as an activator of SOX18 promoter. Exp Mol Med. 42: 132–42.
- Kinzler KW, Vogelstein B (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol. 10: 634–42.
- Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, et al. (2002) Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. Oncogene. 21: 5529–39.
- Kovacevic Grujicic N, Mojsin M, Krstic A, Stevanovic M (2005) Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity. Gene. 344: 287–97.
- Popovic J, Stanisavljevic D, Schwirtlich M, Klajn A, Marjanovic J, Stevanovic M (2014) Expression analysis of SOX14 during retinoic acid induced neural differentiation of embryonal carcinoma cells and assessment of the effect of its ectopic expression on SOXB members in HeLa cells. PLoS One. 9: e91852.
- Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475–89.
- Xuan YH, Jung HS, Choi YL, Shin YK, Kim HJ, Kim KH, et al. (2006) Enhanced expression of hedgehog signaling molecules in squamous cell carcinoma of uterine cervix and its precursor lesions. Mod Pathol. 19: 1139–47.
- Ikram MS, Neill GW, Regl G, Eichberger T, Frischauf AM, Aberger F, et al. (2004) GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter. J Invest Dermatol. 122: 1503–9.
- Eichberger T, Regl G, Ikram MS, Neill GW, Philpott MP, Aberger F, et al. (2004) FOXE1, a new transcriptional target of GLI2 is expressed in human epidermis and basal cell carcinoma. J Invest Dermatol. 122: 1180–7.
- Shevde LA, Samant RS (2014) Nonclassical hedgehog-GLI signaling and its clinical implications. Int J Cancer. 135: 1–6.
- Cooper MK, Porter JA, Young KE, Beachy PA (1998) Teratogen-mediated inhibition of target tissue response to Shh signaling. Science. 280: 1603–7.
- Incardona JP, Gaffield W, Kapur RP, Roelink H (1998) The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development. 125: 3553–62.
- Chen JK, Taipale J, Cooper MK, Beachy PA (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16: 2743–8.
- Sinha S, Chen JK (2006) Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol. 2: 29–30.
- Kenney AM, Rowitch DH (2000) Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol. 20: 9055–67.
- Roy S, Ingham PW (2002) Hedgehogs tryst with the cell cycle. J Cell Sci. 115: 4393–7.
- Wickstrom M, Dyberg C, Shimokawa T, Milosevic J, Baryawno N, Fuskevag OM, et al. (2013) Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Int J Cancer. 132: 1516–24.
- Thu KL, Becker-Santos DD, Radulovich N, Pikor LA, Lam WL, Tsao MS (2014) SOX15 and other SOX family members are important mediators of tumorigenesis in multiple cancer types. Oncoscience. 1: 326–35.
- Castillo SD, Sanchez-Cespedes M (2012) The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin Ther Targets. 16: 903–19.
- Dong C, Wilhelm D, Koopman P (2004) Sox genes and cancer. Cytogenet Genome Res. 105: 442–7.
- Vervoort SJ, van Boxtel R, Coffer PJ (2013) The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Oncogene. 32: 3397–409.
- Zhu Y, Li Y, Jun Wei JW, Liu X (2012) The role of Sox genes in lung morphogenesis and cancer. Int J Mol Sci. 13: 15767–83.
- Vidal VP, Chaboissier MC, Lutzkendorf S, Cotsarelis G, Mill P, Hui CC, et al. (2005) Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment. Curr Biol. 15: 1340–51.
- Lu B, Fang Y, Xu J, Wang L, Xu F, Xu E, et al. (2008) Analysis of SOX9 expression in colorectal cancer. Am J Clin Pathol. 130: 897–904.
- Santini R, Pietrobono S, Pandolfi S, Montagnani V, D'Amico M, Penachioni JY, et al. (2014) SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene. 33: 4697–708.
- Popovic J, Klajn A, Petrovic I, Stevanovic M (2010) Tissue-specific Forkhead protein FOXA2 up-regulates SOX14 gene expression. Biochim Biophys Acta. 1799: 411–8.
- Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, et al. (2011) The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science. 334: 1727–31.
- Woo WM, Zhen HH, Oro AE (2012) Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop. Genes Dev. 26: 1235–46.
- Bohr Mordhorst L, Ahlin C, Sorbe B (2014) Prognostic impact of the expression of Hedgehog proteins in cervical carcinoma FIGO stages I-IV treated with radiotherapy or chemoradiotherapy. Gynecol Oncol. 135: 305–11.
- Chaudary N, Pintilie M, Hedley D, Fyles AW, Milosevic M, Clarke B, et al. (2012) Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation. Cancer. 118: 3105–15.
- Samarzija I, Beard P (2012) Hedgehog pathway regulators influence cervical cancer cell proliferation, survival and migration. Biochem Biophys Res Commun. 425: 64–9.
- Perrot CY, Javelaud D, Mauviel A (2013) Overlapping activities of TGF-beta and Hedgehog signaling in cancer: therapeutic targets for cancer treatment. Pharmacol Ther. 137: 183–99.
- Pierrat MJ, Marsaud V, Mauviel A, Javelaud D (2012) Expression of microphthalmia-associated transcription factor (MITF), which is critical for melanoma progression, is inhibited by both transcription factor GLI2 and transforming growth factor-beta. J Biol Chem. 287: 17996–8004.
- Pula B, Kobierzycki C, Solinski D, Olbromski M, Nowak-Markwitz E, Spaczynski M, et al. (2014) SOX18 expression predicts response to platinum-based chemotherapy in ovarian cancer. Anticancer Res. 34: 4029–37.
- Duman-Scheel M, Weng L, Xin S, Du W (2002) Hedgehog regulates cell growth and proliferation by inducing Cyclin D and Cyclin E. Nature. 417: 299–304.
- Giese A, Loo MA, Tran N, Haskett D, Coons SW, Berens ME (1996) Dichotomy of astrocytoma migration and proliferation. Int J Cancer. 67: 275–82.
- Khoshyomn S, Lew S, DeMattia J, Singer EB, Penar PL (1999) Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression. J Neurooncol. 45: 111–6.
- Merzak A, McCrea S, Koocheckpour S, Pilkington GJ (1994) Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1. Br J Cancer. 70: 199–203.
- Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 3: 362–74.
- Alexandrova AY (2008) Evolution of cell interactions with extracellular matrix during carcinogenesis. Biochemistry (Mosc). 73: 733–41.
- Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol. 11: 1287–96.
- Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, et al. (2010) GLI2-mediated melanoma invasion and metastasis. J Natl Cancer Inst. 102: 1148–59.
- Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, et al. (2004) Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature. 431: 707–12.
- Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya KS, Welch DR, et al. (2011) Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERalpha negative breast cancer cell lines. Clin Exp Metastasis. 28: 437–49.
- Nagai S, Nakamura M, Yanai K, Wada J, Akiyoshi T, Nakashima H, et al. (2008) Gli1 contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase-9 activation. Cancer Sci. 99: 1377–84.
- Hoeth M, Niederleithner H, Hofer-Warbinek R, Bilban M, Mayer H, Resch U, et al. (2012) The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells. PLoS One. 7: e30982.
- Luo M, Guo XT, Yang W, Liu LQ, Li LW, Xin XY (2008) Inhibition of tumor angiogenesis by cell-permeable dominant negative SOX18 mutants. Med Hypotheses. 70: 880–2.
Source: PubMed